Anneli Uusküla

https://www.etis.ee/CV/Anneli_Uusküla/est
11.04.1967
737 4195
anneli.uuskula@ut.ee
H-3303-2015

Teenistuskäik

Töökohad ja ametid
01.02.2018–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, epidemioloogia professor (1,00)
2007–...   
Tartu Ülikool, Arstiteaduskond, Professor (1,00)
2000–...   
SA Tartu Ülikooli Kliinikum, tartu Ülikooli Kliinikumi Nahakliinik, arst-õppejõud (0,25)
01.01.2016–31.01.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, rahvatervishoiu magistriõppekava programmijuht
01.01.2016–31.01.2018   
Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut, epidemioloogia professor (1,00)
01.02.2013–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Arstiteaduskonna dekanaat, rahvatervishoiu magistriõppekava programmijuht
01.02.2013–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia professor (1,00)
01.02.2008–31.01.2013   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia professor (1,00)
01.02.2008–28.02.2009   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia erakorraline professor (0,50)
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja
01.03.2007–31.01.2008   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia vanemteadur (0,50)
01.02.2007–28.02.2007   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, instituudi juhataja kohusetäitja
2007–2009   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, Juhataja (0,25)
01.01.2005–28.01.2007   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemassistent (0,25)
01.05.2004–28.02.2007   
Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut, epidemioloogia vanemteadur (0,75)
 
 
Haridustee
2001–2003   
State University of New York, magistriõpe (epidemioloogia)
1997–2001   
Tartu Ülikool, doktoriõpe
1993–1997   
Tartu Ülikool, residentuur (dermatoveneroloogia)
1991–1993   
Tartu Ülikool, internatuur
1958–1991   
Tartu Ülikool, arstiteaduskond
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2013−...   
Ajakirja BMC infectious diseases toimetaja
2012−...   
Eesti Haigekassa, ravijuhiste nõukogu, liige
2011−...   
Ajakiri Eesti arst, teadustoimetaja
2009−...   
Eesti teadusagentuur, tervise valdkonna ekspert komimsjon, liige
2009−...   
Euroopa haiguskontrolli keskus, ekspert
2006−...   
Eesti dermatoveneroloogide selts, president (President); juhatuse liiga alates 2012
2005−...   
Euroopa Ravimiagentuuri (European Medicines Agency, EMEA), valideeritud ekspert
2004−...   
Vabariigi valitsuse HIV ja AIDSi riikliku komisjoni liige
1999−...   
Riigi Ravimiameti ekspert (dermatoloogia)
1997−...   
New York Academy of Sciences liige
Ekspertkomisjonid
2004−2008   
European Surveillance of Sexually Transmitted Infections (ESSTI), töögrupi liige
1999−2010   
Sugulisel teel levivate infektsioonide Eesti Ühing (juhatuse liige)
 
 
Lisainfo
Saadud uuringu toetused (lõpetatud)

National institutes of health (USA)/NIAID R01AI083035
06/2009-08/2014
Juhtpartner - DesJarlais D (Beth Isreal Med Center, NY, USA)
Multiple Prevention Programs Project for IDUs in Eastern Europe (Estonia)

European Commission/ Leonardo da Vinci Programme
01/2013-12/2015
Juhtpartner – McNulty C (HPA, UK)
Chlamydia Testing Training Into Europe (CaTTE)

European Centre for Disease Prevention and Control (ECDC)
01/2012-04/2014
Juhtpartner – Low N (Univ Bern, Switzerland)
Chlamydia Control in Europe

Norwegian Financial Mechanism / EEA grant EE0016
11/2007 – 05/2011
Juhtpartner – Uusküla A/Kiivet R
Capacity building for disease surveillance and health monitoring in Estonia

National institutes of health (USA) / FIC R01 TW06990-01
07/2004-07/2010
Juhtpartner - Uuskula A
Homescreening for sexually transmitted infections in Estonia

Merck (USA) Investigator initiated research program MISP #38078
12/2010-12/2013
Juhtpartner – Uusküla A (Univ Tartu)
The Burden of Genital Warts: a study from three Baltic countries

National institutes of health (USA) / NIDA R01 003574
09/2005 - 08/2010
Juhtpartner - Des Jarlais DC
Risk Factors for AIDS among IV Drug Users

European Centre for Disease prevention and Control OJ/2008/04/11 – PROC/2008/006
06/2008-05/2010
Juhtpartner – Low N
Evaluating the public health benefits of partner notification

Civilian Research & Development Foundation (USA) ESB1-7002-TR-08
10/2008 - 12/2010
Juhtpartner – Uusküla A
HIV Transmission Among Injecting and Non-Injecting Drug Users in Tallinn, Estonia

Civilian Research & Development Foundation (USA) ESXO-002722-TA06
Juhtpartner - Uusküla A
Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners.
02/2006-01/2008
;

Kvalifikatsioon

Teaduskraadid
Anneli Uusküla, magistrikraad (teaduskraad), 2003, (juh) Louise-Anne McNutt, Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles, State University of New York at Albany, School of Public Health.
Anneli Uusküla, doktorikraad, 2001, (juh) Helgi Silm, Epidemiology of sexually transmitted diseases in Estonia in 1990 - 2000 (Seksuaalsel teel levivate haiguste epidemioloogia Eesti aastatel 1990–2000), Tartu Ülikool, Arstiteaduskond.
 
 
Teaduspreemiad ja tunnustused
2001, Anneli Uusküla, NIH Fellowship, Fogarty International Center (State University of New York, School of Public Health, Albany, NY)
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.6. Rahvatervishoid
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.7. Kliiniline meditsiin

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

Klass
Aasta
Publikatsioon
 
5.2.
2019
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade. Eesti Arst, 98: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskoneverents 2019. Tartu: Celsius Healthcare , 32−32. (lisa 3).
5.2.
2019
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Understanding risk factors and warning signs for suicide. In: .
1.1.
2018
Tavitian-Exley, Isabel; Maheu-Giroux, Mathieu; Platt, Lucy; Heimer, Robert; Uusküla, Anneli; Levina, Olga; Vickerman, Peter; Boily, Marie-Claude (2018). Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. The International journal on drug policy, 53, 96−105.10.1016/j.drugpo.2017.11.010.
1.1.
2018
Werb, Dan; Bluthenthal, R. N.; Kolla, G.; Strike, C.; Kral, A. H.; Uuskula, A.; Des Jarlais, D. (2018). Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. Journal of Urban Health, 95 (1), 91−98.10.1007/s11524-017-0192-8.
1.1.
2018
Chan, Pui Y; Joseph, Michael A; Des Jarlais, Don C; Uusküla, Anneli (2018). Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia. International journal of STD & AIDS, 29 (1), 13−22.10.1177/0956462417714635.
1.1.
2018
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; HIV-BRIDGE Study Group (2018). Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS and Behavior, 22 (1), 224−233.10.1007/s10461-017-1859-6.
1.1.
2018
Jõgeda, E-L; Avi, R; Pauskar, M; Kallas, E; Karki, T; Des Jarlais, D; Uusküla, A; Toompere, K; Lutsar, I; Huik, K (2018). Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. Journal of Medical Virology, 90 (11), 1779−1783.10.1002/jmv.25258.
1.1.
2018
Tavitian-Exley, Isabel; Boily, Marie-Claude; Heimer, Robert; Uuskula, Anneli; Levina, Olga; Maheu-Giroux, Mathieu (2018). Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis. AIDS and Behavior, 22 (4), 1329−1340.10.1007/s10461-017-1836-0.
1.1.
2018
Tisler-Sala, Anna; Ojavee, Sven-Erik; Uuskula, Anneli (2018). Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associated with non-compliant prescribing: findings form a cross-sectional study. Sexually Transmitted Infections, 94 (4), 297−302.10.1136/sextrans-2017-053247.
1.1.
2018
Kivimets, Kristel; Uuskula, Anneli; Lazarus, Jeffrey V.; Ott, Kristi (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infectious Diseases, 18, ARTN 339.10.1186/s12879-018-3242-2.
1.1.
2018
Uusküla, Anneli; Pisarev, Heti; Kurvits, Katrin; Laius, Ott; Laanpere, Made; Uusküla, Maia (2018). Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016. Drugs - Real World Outcomes, 5 (2), 129−136.10.1007/s40801-018-0135-z.
1.1.
2018
Des Jarlais, Don C.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Barnes, David M.; Perlman, David C.; Uuskula, A.; Cooper, H. L. F.; Tross, Susan (2018). Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Drug and Alcohol Dependence, 192, 74−79.10.1016/j.drugalcdep.2018.07.034.
2.5.
2018
Rooväli, L.; Pisarev, H.; Suija, K.; Aksen, M.; Uusküla, A.; Kiivet; RA: (2018). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade.
5.2.
2018
Lemsalu L, Rice B, Uusküla A, Raag M, Lutsar I, Rüütel K (2018). How to ascertain an accurate number of people living with diagnosed HIV and fill data gaps from the past - lessons learned from a high prevalence setting in Europe. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society,.
5.2.
2018
Lemsalu L, Uusküla A, Rice B, Raag M, Rüütel K (2018). Drug overdose is the most common cause of death among HIV infected people in Estonia. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society,.
1.1.
2017
Johannson A, Vorobjov S, Heimer R, Dovidio JF, Uusküla A. (2017). The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, Estonia. AIDS and Behavior, 21 (4), 1034−1043.10.1007/s10461-016-1647-8.
1.1.
2017
Anneli Uusküla, Mait Raag, Kristina Marsh, Ave Talu, Sigrid Vorobjov, Don Des Jarlais (2017). HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLOS ONE, 12 (2), e0170956.10.1371/journal.pone.0170956.
1.1.
2017
Jogeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Karki, Tonis; Jarlais, Don Des; Uuskula, Anneli; Lutsar, Irja; Avi, Radko (2017). Prevalence and Genotypes of GBV-C and Its Associations With HIV Infection Among Persons Who Inject Drugs in Eastern Europe. Journal of Medical Virology, 89 (4), 632−638.10.1002/jmv.24683.
1.1.
2017
Wu, Jiacheng; Crawford, Forrest W; Raag, Mait; Heimer, Robert; Uusküla, Anneli (2017). Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. PLoS ONE, 12 (11), e0185711−e0185711.10.1371/journal.pone.0185711.
1.1.
2017
Mikk Jürisson, Mait Raag, Riina Kallikorm, Margus Lember, Anneli Uusküla (2017). The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskeletal Disorders, 18 (243), 1−10.10.1186/s12891-017-1606-1.
1.1.
2017
Võrno, Triin; Lutsar, Katrin; Uusküla, Anneli; Padrik, Lee; Raud, Terje; Reile, Rainer; Nahkur, Oliver; Kiivet, Raul-Allan (2017). Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Vaccine, 35 (46), 6329−6335.10.1016/j.vaccine.2017.08.083.
1.1.
2017
Heimer, Robert; Usacheva, Nina; Barbour, Russell; Niccolai, Linda M; Uusküla, Anneli; Levina, Olga S (2017). Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia. Addiction (Abingdon, England), 112 (8), 1421−1431.10.1111/add.13798.
1.1.
2017
McNulty C, Ricketts EJ, Fredlund H, Uusküla A, Town K, Rugman C, Tisler-Sala A, Mani A, Dunais B, Folkard K, Allison R, Touboul P. (2017). Qualitative interviews with healthcare staff in four European countries to inform adaptation of an intervention to increase chlamydia testing. BMJ Open, 7 (9), e017528.10.1136/bmjopen-2017-017528.
1.1.
2017
Wiessing, Lucas; Ferri, Marica; Běláčková, Vendula; Carrieri, Patrizia; Friedman, Samuel R; Folch, Cinta; Dolan, Kate; Galvin, Brian; Vickerman, Peter; Lazarus, Jeffrey V; Mravčík, Viktor; Kretzschmar, Mirjam; Sypsa, Vana; Sarasa-Renedo, Ana; Uusküla, Anneli; Paraskevis, Dimitrios; Mendão, Luis; Rossi, Diana; van Gelder, Nadine; Mitcheson, Luke ... Griffiths, Paul (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm reduction journal, 14 (1), 19−19.10.1186/s12954-017-0141-6.
1.1.
2017
Lemsalu, L.; Rüütel, K.; Laisaar, KT.; Lõhmus, L.; Raidvee, A.; Uusküla, A.; HIV-BRIDGE Study Group (2017). Suicidal Behavior Among People Living with HIV (PLHIV) in Medical Care in Estonia and Factors Associated with Receiving Psychological Treatment. AIDS Behav, 21 (6), 1709−1716.10.1007/s10461-016-1561-0.
5.2.
2017
Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; Uusküla, Anneli; and the HIV-BRIDGE Study Group (2017). Patient characteristics to consider when supporting antiretroviral therapy adherence in people living with HIV: a randomized controlled trial in Estonia. Conference Abstract Book: 12th International Conference on HIV Treatment and Prevention Adherence (ADHERENCE 2017); Miami, FL, USA: 04.-06.06.2017. International Association of Providers of AIDS Care (IAPAC), 84−84.
1.1.
2016
Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jõgeda, Ene-Ly; Karki, Tõnis; Rüütel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uusküla, Anneli; Carrillo, Andrew; Ahuja, Sunil K; He, Weijing; Lutsar, Irja (2016). A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs. PLOS ONE, 11 (6), e0156850−e0156850.10.1371/journal.pone.0156850.
1.1.
2016
van den Broek, Ingrid V.; Sfetcu, Otilia; van der Sande, Marianne A.; Andersen, Berit; Herrmann, Björn; Ward, Helen; Götz, Hannelore M.; Uusküla, Anneli; Woodhall, Sarah C.; Redmond, Shelagh M.; Amato-Gauci, Andrew J.; Low, Nicola; van Bergen, Jan E. (2016). Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. European journal of public health, 26 (3), 382−388.10.1093/eurpub/ckv196.
1.1.
2016
Calabrese, Sarah K.; Burke, Sara E.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Heimer, Robert (2016). Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS and behavior, 20 (1), 85−97.10.1007/s10461-015-1100-4.
1.1.
2016
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2016). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 2016 (9), Article number CD010866.10.1002/14651858.CD010866.pub2.
1.1.
2016
Jürisson, Mikk; Pisarev, Heti; Kanis, John; Borgström, Fredrik; Svedbom, Axel; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli (2016). Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporosis International, 27 (8), 2555−2566.10.1007/s00198-016-3544-4.
1.1.
2016
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical microbiology and immunology, 205 (3), 231−239.10.1007/s00430-015-0444-8.
1.1.
2016
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi (2016). Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infection, Genetics and Evolution, 43, 83−85.10.1016/j.meegid.2016.05.022.
1.1.
2016
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral immunology, 0−0.vim.2016.0057.
1.1.
2016
Laisaar, K.T.; Raag, M.; Lutsar, I.; Uusküla, A. (2016). People living with HIV in Estonia: engagement in HIV care in 2013. Eurosurveillance, 21 (43), x−x.10.2807/1560-7917.ES.2016.21.43.30380.
5.2.
2016
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, KT., Uusküla, A., for OptTEST by HIV in Europe (2016). Changes in quality of life of PLHIV in Estonia from 2005 to 2013. 21st International AIDS Conference, Durban, South Africa, July 18-22, 2016. International AIDS Society, 143.
1.1.
2015
Uusküla, Anneli; Reile, Rainer; Rezeberga, Dace; Karnite, Anda; Logminiene, Zenetha; Padaiga, Zilvinas; Nygård, Mari. (2015). The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania. Sexually Transmitted Infections, 91 (1), 55−60.10.1136/sextrans-2014-051540.
1.1.
2015
Shelagh M. Redmond, Karin Alexander-Kisslig, Sarah C. Woodhall, Ingrid V. F. van den Broek, Jan van Bergen, Helen Ward, Anneli Uusküla, Björn Herrmann, Berit Andersen, Hannelore M. Götz, Otilia Sfetcu, Nicola Low (2015). Genital Chlamydia prevalence in europe and non-European high income countries: systematic review and meta-analysis. PLoS ONE, 10 (1), e0115753.10.1371/journal.pone.0115753.
1.1.
2015
Uusküla, A.; Erm, T. (2015). Disseminated Giant Hyperkeratotic Porokeratosis and Treatment with Acitretin: A Case Report. Acta Dermato-Venereologica, 95 (2), 241−242.10.2340/00015555-1908.
1.1.
2015
Feelemyer, J.; Des Jarlais, D.; Arasteh, K.; Uusküla, A. (2015). Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review. AIDS and Behavior, 19 (4), 575−583.10.1007/s10461-014-0928-3.
1.1.
2015
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. (2015). An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. International Journal of Drug Policy, S0955-3959(15)00126-7.
1.1.
2015
Uusküla, A.; Des Jarlais, D.C.; Raag, M.; Pinkerton, S.D.; Feelemyer, J. (2015). Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS care, 27 (1), 105−11.10.1080/09540121.2014.940271.
1.1.
2015
Jürisson, Mikk; Vorobjov, Sigrid; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli. (2015). The incidence of hip fractures in Estonia, 2005–2012. Osteoporosis International, 26 (1), 77−84.10.1007/s00198-014-2820-4.
1.1.
2015
Morozova, Olga; Levina, Olga; Uusküla, Anneli; Heimer, Robert (2015). Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia. BMC medical research methodology, 15 (71), 71−71.10.1186/s12874-015-0066-2.
1.1.
2015
Burke, Sara E; Calabrese, Sarah K; Dovidio, John F; Levina, Olga S; Uusküla, Anneli; Niccolai, Linda M; Abel-Ollo, Katri; Heimer, Robert (2015). A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social science & medicine (1982), 130, 154−161.10.1016/j.socscimed.2015.02.018.
1.1.
2015
Laisaar, Kaja-Triin; Raag, Mait; Rosenthal, Marika; Uusküla, Anneli (2015). Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review. AIDS Patient Care and STDs, 29 (5), 288−289.10.1089/apc.2014.0240.
1.1.
2015
Uuskuela, Anneli; Raag, Mait; Vorobjov, Sigrid; Rueuetel, Kristi; Lyubimova, Alexandra; Levina, Olga S.; Heimer, Robert (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. BMC Public Health, 15, ARTN 1255.10.1186/s12889-015-2604-6.
1.1.
2015
Uusküla, A.; Toompere, K.; Laisaar, KT.; Rosenthal, M.; Pürjer, ML.; Knellwolf, A.; Läärä, E.; Des Jarlais, DC. (2015). HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open, 5 (2), e006591−8.10.1136/bmjopen-2014-006591.
2.5.
2015
Jürisson, Mikk; Taba, Pille; Võrno, Triin; Abram, Mikk; Eiche, Ivar-Endrik; Uusküla, Anneli (2015). Puukentsefaliidivastase vaktsineerimise kulutõhusus Eestis. Tartu: Tartu Ülikooli tervishoiu instituut.
5.2.
2015
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Jarlais, Don Des; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi; (2015). HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs). Retrovirology, 12, P79−P79.10.1186/1742-4690-12-S1-P79.
5.2.
2015
Laisaar, K.T., Raag, M., Rüütel, K., Lemsalu, L., Lõhmus, L., Uusküla, A. (2015). Measuring Antiretroviral Therapy Adherence in Clinical Care Settings in Estonia. 10th International Conference on HIV Treatment and Prevention Adherence, Miami, USA, June 28-30 2015. International Association of Providers of AIDS Care, 103.
1.1.
2014
Kivimets K, Uuskula A. (2014). HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts. Eurosurveillance, 19 (47), 31−37.
1.1.
2014
Uusküla A, Ricketts EJ, Rugman C, Kalda RR, Fredlund H, Hedlund J, Dunais B, Touboul PP, McNulty C (2014). Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries. BMC Public Health, 14, 1147.10.1186/1471-2458-14-1147.
1.1.
2014
DeHovitz, J.; Uuskula, A.; El-Bassel, N. (2014). The HIV epidemic in Eastern Europe and Central Asia. Current HIV/AIDS Reports, 11 (2), 168−176.10.1007/s11904-014-0202-3.
1.1.
2014
Burke, S.E.; Calabrese, S.K.; Dovidio, J.F.; Levina, O.S.; Uusküla, A.; Niccolai, L.M.; Abel-Ollo, K.; Heimer, R. (2014). A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social science and medicine, 130, 154−162.10.1016/j.socscimed.2015.02.018.
1.1.
2014
Huik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I. (2014). Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population. Jaids-Journal of Acquired Immune Deficiency Syndromes, 66 (3), 239−244.10.1097/QAI.0000000000000127.
1.1.
2014
Rüütel, Kristi; Karnite, Anda; Talu, Ave; Abel-Ollo, Katri; Kirvelaite, Gunta; Kliiman, Kai; Loit, Helle-Mai; Uusküla, Anneli. (2014). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy, 25 (1), 175−178.10.1016/j.drugpo.2013.10.002.
1.1.
2014
Rahu, K.; Bromet, E. J.; Hakulinen, T.; Auvinen, A.; Uusküla, A.; Rahu, M. (2014). Non-cancer morbidity among Estonian Chernobyl cleanup workers: a register-based cohort study. BMJ Open, 4, e004516.10.1136/bmjopen-2013-004516.
1.1.
2014
Uusküla, A.; Raag, M.; Folch, C.; Prasad, L.; Karnite, A.; van Veen, M.G.; Eritsyan, K.; Rosinska, M.; Des Jarlais, D.C.; Wiessing, L. (2014). Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS, 28 (11), 1657−64.10.1097/QAD.0000000000000299.
2.5.
2014
Männik, Agnes; Suuroja, Tiit; Juus, Eva; Võrno, Triin; Uusküla, Anneli; Reile, Rainer; Orav, Kateriine; Kiivet, Raul-Allan (2014). Kolorektaalvähi sõeluringu kulutõhusus. 1−113.
2.5.
2014
Lõhmus, L.; Lemsalu, L.; Rüütel, K.; Laisaar, K.-T.; Uusküla, A. (2014). Infektsionisti külastavate HIV-i nakatunud inimeste tervis. 2013. aasta terviseuuringu raport.
3.4.
2014
Laisaar, Kaja-Triin; Raag, Mait; Rasva, Heli; Uusküla, Anneli (2014). Engagement in the continuum of HIV care in Estonia. 337.
5.2.
2014
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, K-T., Uusküla, A. (2014). Suicidality is common among HIV infected people in Estonia and is associated with lack of psychological help. 15th European Symposium on Suicide and Suicidal Behaviour, Tallinn, Estonia, 27-30.08.2014. European Symposium on Suicide and Suicidal Behaviour, 280.
1.1.
2013
Liivlaid, H; Uusküla, A (2013). Changes in high-risk sexual behaviour among Estonian adults between 1996 and 2006. Sexually Transmitted Infections, 89 (2), 91−97.10.1136/sextrans-2012-050506.
1.1.
2013
Karnite, A.; Brigis, G.; Uusküla, A. (2013). Years of potential life lost due to HIV infection and associated factors based on national HIV surveillance data in Latvia, 1991-2010. Scandinavian Journal of Infectious Diseases, 45 (2), 140−146.10.3109/00365548.2012.717710.
1.1.
2013
Vickerman, P; Martin, NK; Roy, A; Beattie, T; EMCDDA Collaborative Group, Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M (2013). Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and Alcohol Dependence, 132, 172−182.10.1016/j.drugalcdep.2013.01.020.
1.1.
2013
Laisaar, KT; Uusküla, A; Sharma, A; DeHovitz, JA; Amico, KR (2013). Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS care, 25 (7), 863−873.10.1080/09540121.2013.764393.
1.1.
2013
Huik, K; Avi, R; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection, Genetics and Evolution, 20, 78−82.10.1016/j.meegid.2013.08.008.
1.1.
2013
Huik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I (2013). CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users. PLoS ONE, 8 (7), e70561.10.1371/journal.pone.0070561.
1.1.
2013
Uusküla, Anneli; Rajaleid, Kristiina; Talu, Ave; Abel-Ollo, Katri; Des Jarlais, Don (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal of Drug Policy, 24 (4), 312−318.10.1016/j.drugpo.2012.11.002.
1.1.
2013
Vorobjov, S; Des Jarlais, DC; Abel-Ollo, K; Talu, A; Rüütel, K; Uusküla, A (2013). Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. International Journal of Drug Policy, 24 (2), 150−155.10.1016/j.drugpo.2012.08.003.
1.1.
2013
Puur, A., Altmets, K., Saava, A., Uusküla, A., Sakkeus, L. (2013). Non-fatal injuries resulting in activity limitations in Estonia: risk factors and association with the incidence of chronic conditions and quality of life. A retrospective study among the population aged 20-79. BMJ Open, 3, 1−7.10.1136/bmjopen-2013-002695.
1.1.
2013
Anneli Uusküla, A.; Müürsepp, A.; Kawai, K.; Raag, M.; Jürisson, M.; Pillsbury, M. (2013). The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia. BMC Infectious Diseases, 13, No 304.10.1186/1471-2334-13-304.
1.1.
2013
Uusküla, A.; Raag, M.; Uppin, A.; Raud, T.; Klaar, U.; Jürisson, M.; Müürsepp, A. (2013). Incidence of Cervical Intraepithelial Neoplasia in Estonia. Journal of Lower Genital Tract Disease, 17 (2), 129−136.10.1097/LGT.0b013e3182652213.
1.2.
2013
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2013). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 12, x−x.10.1002/14651858.CD010866.
1.2.
2013
Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, Hatzatkis A, Uuskula A. (2013). 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Advances in Preventive Medicine, 2012, 346372.
1.3.
2013
Anderson, Eva; Toompere, Karolin; Reile, Rainer; Uusküla, Anneli (2013). Naiste teadlikkus emakakaelavähki ennetavatest meetmetest Eestis 2011. aastal. Eesti Arst, 92 (4), 195−203.
1.3.
2013
Uusküla, A (2013). Ajas muutuvad eesmärgid. Eesti Arst, 92 (5), 244−246.
5.2.
2013
Jõgeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Krispin, Tõnu; Karki, Tõnis; Marsh, Kristina; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja. (2013). The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users. Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013. 46−47.
5.2.
2013
Raag, Mait; Uusküla, Anneli; Des Jarlais, Don; Wiessing, Lucas (2013). Relationship between risk behaviour and awareness of HIV status among injecting drug users: a multisite study. European Journal of Epidemiology, 28: European Congress on Epidemiology 2013, Aarhus, Taani, 2013. Springer, S195−S196.10.1007/s10654-013-9820-0.
1.1.
2012
Uusküla, A.; Laisaar, K.-T.; Raag, M.; Smidt, J.; Semjonova, S.; Kogan, J.; Amico K, R.; Sharma, A.; Dehovitz , J. (2012). Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS care, 24 (12), 1470−1479.10.1080/09540121.2012.672724.
1.1.
2012
Vorobjov S, Uusküla A, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K. (2012). Multiple routes of drug administration and HIV risk among injecting drug users. The Journal of Substance Abuse Treatment, 42 (4), 413−420.
5.1.
2012
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Šmidt, Jelena; Semjonova, Svetlana; Kogan, Juta; Amico, K. Rivet; Sharma, Anjali; DeHovitz, Jack (2012). Antiretroviral therapy (ART) adherence and correlates to non-adherence among people on ART in Estonia. Retrovirology: 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID); 23-25 May 2012; Marseille, France. Biomed Central Ltd, P80. (9(Suppl 1)).10.1186/1742-4690-9-S1-P80.
5.2.
2012
Uibopuu, H.; Huik, K.; Avi, R.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Kool, P.; Schmidt, J.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Lutsar, I. (2012). Viral tropism of HIV-1 CRF06_cpx and its association with CCR5 haplotypes. 10th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 28 - 30 March 2012 Barcelona Spain.
1.1.
2011
Uusküla, A.; Abel-Ollo, K.; Markina, A.; McNutt, LA.; Heimer, R. (2011). Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia. Sexually Transmitted Infections, 88 (1), 58−62.10.1136/sextrans-2011-050195.
1.1.
2011
Uusküla, A.; Kals, M; McNutt, LA. (2011). Assessing non-response to a mailed health survey including self-collection of biological material. European Journal of Public Health, 21 (4), 538−542.10.1093/eurpub/ckq053.
1.1.
2011
Laisaar, K.-T.; Avi, R.; Dehovitz, J.; Uusküla, A. (2011). Estonia at the Threshold of the Fourth Decade of the AIDS Era in Europe. Aids Research and Human Retroviruses, 27 (8), 841−851.10.1089/aid.2010.0223.
1.1.
2011
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 30 (11), 517.10.1186/1471-2458-11-517.
1.1.
2011
Altmets, K.; Puur, A. ; Uusküla, A.; Saava, A.; Sakkeus, L.; Katus, K. (2011). Self-reported activity limitations among the population aged 20-79 in Estonia: a cross-sectional study. European Journal of Public Health, 21 (1), 49−55.10.1093/eurpub/ckp239.
1.2.
2011
Rüütel, Kristi; Loit, Helle-Mai; Sepp, Tiiu; Kliiman, Kai; McNutt, Louise-Anne; Uusküla, Anneli. (2011). Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Research Notes, 192.
1.3.
2011
Uusküla, A. (2011). KONSTANDID NÕUAVAD TÄHELEPANU. Akadeemia, 1, 144−152.
1.3.
2011
Saava, Astrid;Puur, Allan;Altmets, Katre;Sakkeus, Luule;Uusküla, Anneli (2011). Toimetulekupiiranguid põhjustanud vigastused Eestis: rahvastikupõhine sündmuslooline uuring. Eesti Arst, 90, 4, 165−173.
2.5.
2011
Briljene, T.; Haldre, K.; Karro, H.; Konno, P.; Kukk, T.; Maimets, M.; Punab, M.; Põder, A.; Silm, H.; Szirko, F.; Sõritsa, A.; Zilmer, K.; Tamm, T.; Tammemäe, L.; Timberg, G.; Uusküla, A. (2011). Seksuaalsel teel levivate infektsioonide ravijuhised Eestis.
2.5.
2011
Liiv, Kristi; Lutsar, Katrin; Palm, Eva; Uusküla, Anneli; Kiivet, Raul-Allan (2011). Inimese papilloomiviiruse vastaste vaktsiinide kulutõhusus Eestis. Tartu: Tartu Ülikool, tervishoiu instituut.
3.2.
2011
Lioznov D, Rüütel K, Uusküla A, DeHovitz J (2011). AIDS in Eastern Europe and Central Asia. In: Hall JC, Hall BJ, Cockerell CJ (_EditorsAbbr). HIV/AIDS IN THE POST-HAART ERA: Manifestations, Treatment & Epidemiology (820).. P. Lang.
1.1.
2010
Uusküla, A.; Kals, M.; Kosenkranius, L.; McNutt, LA.; DeHovitz, JJ. (2010). Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infectious Diseases, 10, Article Number: 63.10.1186/1471-2334-10-63.
1.1.
2010
Uusküla, A.; McMahon, JM.; Raag, M.; Silm, S.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Ahas, R.; Des Jarlais, DC. (2010). Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors. Sexually Transmitted Infections, 86, 3, 79−84.
1.1.
2010
Uusküla, A.; Johnston, L.G.; Raag, M.; Trummal, A.; Talu, A.; Des Jarlais, D.C. (2010). Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent driven sampling in Estonia. Journal of Urban Health, 87 (2), 304−317.10.1007/s11524-009-9427-7.
1.1.
2010
Talu, A.; Rajaleid, K.; Abel-Ollo, K.; Rüütel, K.; Rahu, M.; Rhodes, T.; Platt, L.; Bobrova, N.; Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for intervention. International Journal of Drug Policy, 21 (1), 56−63.10.1016/j.drugpo.2009.02.007.
1.1.
2010
Huik, K.; Sadam, M.; Karki, T.; Avi, R.; Krispin, T.; Paap, P.; Rüütel, K.; Uusküla, A.; Talu, A.; Abel-Ollo, K.; Lutsar, I. (2010). CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. The Journal of Infectious Diseases, 730−739.
1.1.
2010
Uusküla A, Puur A, Toompere K, DeHovitz J. (2010). Trends in the epidemiology of bacterial sexually transmitted infections in Eastern Europe, 1995-2005: review. Sexually Transmitted Infections, 86, 6−14.10.1136/sti2009.037044.
5.1.
2010
Laisaar, Kaja-Triin; Uusküla, Anneli, Sharma, Anjali; DeHovitz, Jack (2010). Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia. Retrovirology: 16th International Symposium on HIV and Emerging Infectious Diseases; 24-26 March 2010; Marseille, France. Biomed Central Ltd, P142. (7(Suppl 1)).10.1186/1742-4690-7-S1-P142.
1.1.
2009
McNutt, L.A.; Gordon, EJ; Uuskula, A. (2009). Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Medical Ethics, 10, 14.
1.1.
2009
Vorobjov, S.; Uusküla, A.; Abel-Ollo, K.; Talu, A.; Des Jarlais, D. (2009). Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Journal of Urban Health, 86 (6), 918−928.
1.1.
2009
Abel-Ollo, K.; Rahu, M.; Rajaleid, K.; Talu, A.; Rüütel, K.; Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A. (2009). Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS care, 21 (7), 851−857.
1.1.
2009
Vorobjov, S.; Uuskula, A.; Abel-Ollo, K.; Talu, A.; Ruutel, K.; Des Jarlais, D.C. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm reduction journal, 6 (1), 3.
1.2.
2009
Paat, G. ; Uusküla, A.; Tefanova, V.; Tallo, T.;Priimägi, L.;Ahi, K. (2009). The trends and risk factors for hepatitis B occurrence in Estonia. Central European Journal of Public Health, 17, 108−111.
1.2.
2009
Rüütel, K, Pisarev, H, Loit, HM, Uusküla, A. (2009). Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey. Journal of the International AIDS Society, 12, 13.
1.3.
2009
Uusküla, A.; Jürisson, M.; Võrk, A.; Kallikorm, R. (2009). Sõeluuringu rakendamise põhjendatus osteoporoosi varaseks diagnoosimiseks Eestis. Eesti Arst, 402−413.
1.1.
2008
Uusküla, A.; Fischer, K.; Raudne, R.; Kilgi, H.; Krylov, R.; Salminen, M.; Brummer-Korvenkontio, H.; St Lawrence, J.; Aral, S. (2008). A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sexually Transmitted Infections, 84 (3), 189−191.10.1136/sti.2007.027664.
1.1.
2008
Uusküla, A.; Kals, M.; Denks, K.; Nurm, U.; Kasesalu, L.; Dehovitz, J.; McNutt, L.A. (2008). The prevalence of chlamydial infection in Estonia: a poplation-based survey. International Journal of STD & Aids, 19 (7), 455−458.10.1258/ijsa.2008.007325.
1.1.
2008
Uusküla, A.; Kals, M.; Rajaleid, K.; Abel, K.; Talu, A.; Rüütel, K.; Platt, L.; Rhodes, T.; Dehovitz, J.; Des Jarlais, D. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. Journal of Public Health, 30 (2), 119−125.10.1093/pubmed/fdn014.
1.2.
2008
Rüütel K, Uusküla A, Minossenko A, Loit HM (2008). Quality of life of people living with HIV and AIDS in Estonia. Central European Journal of Public Health, 16 (3), 111−115.
1.3.
2008
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Toimetulekupiirangud Eesti täisealises rahvastikus - levimus ja tegelik abistamine. Eesti Arst, 87 (2), 92−101.
3.2.
2008
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2008). Seasonal variability of human reproduction in Estonia. In: Roosaare, J.; Mander, Ü. (_EditorsAbbr). Estonia. Geographical Studies (19−41).. Tartu: Tartu Ülikooli Kirjastus. (Publicationes Instituti Geographici Universitatis Tartuensis; 107).
5.1.
2008
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Activity limitations among adult population: evidence of Estonian family and fertility survey. European Population Conference 2008. Programme and Abstracts: European Population Conference 2008. Migration and Migrants in Europe; Barcelona, Spain; 9-12.07.2008. European Association for Population Studies in association with Centre d`Estudis Demogràfics, 355−355.
5.2.
2008
Sadam, M.; Karki, T.; Huik, K.; Avi, R.; Rüütel, K.; Uusküla, A.; Lutsar, I (2008). CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1/AIDS Among Estonian Intravenous Drug User. The 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, 03.02-06.02.2008.
1.1.
2007
Uusküla, A.; McNutt, L.A.; Dehovitz, J.; Fischer, K.; Heimer, R. (2007). High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD & Aids, 18 (1), 41−46.
1.1.
2007
Wilson, T.E.; Sharma, A.; Zilmer, K.; Kalikova, N.; Uusküla, A. (2007). The HIV prevention needs of injection drug users in Estonia. International Journal of STD & Aids, 18 (6), 389−391.
1.1.
2007
Uusküla, A.; Rajaleid, K.; Talu, A.; Abel, K.; Rüütel, K.; Hay, G. (2007). Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research and Theory, 15 (4), 411−424.
1.3.
2007
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
5.2.
2007
Altmets K., Katus K., Puur A., Saava A., Uusküla A. (2007). Toimetulekupiirangute levimus Eesti täisealises rahvastikus. Eesti Arst, 86. Eesti Arst, 679−680. (9).
1.1.
2006
Uuskula, A.; Heimer, R.; DeHovitz, J.; Fischer, K.; McNutt, LA. (2006). Surveillance of HIV, hepatitis B virus, and hepatitis c virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance. Journal of Infectious Diseases, 193 (3), 455−457.
1.1.
2006
Aral, S.O.; St Lawrence, J.S.; Uusküla, A. (2006). Sex Work in Tallinn, Estonia: The Socio-spatial Penetration of Sex Work into Society. Sexually Transmitted Infections, 82 (5), 348−353.
1.1.
2006
Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.; Parry, JV.; Rüütel, K.; Talu, A.; Abel, K.; Rajaleid, K.; Judd, A. (2006). High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS, 20 (16), 2120−2123.
1.1.
2006
Uuskula, A.; Kangur, K.; McNutt, L.A. (2006). Barriers to effective STI screening in a post-Soviet society: results from a qualitative study. Sexually Transmitted Infections, 82 (4), 323−326.
1.1.
2006
Rüütel, K.; Uusküla, A. (2006). HIV epidemic in Estonia in the third decade of AIDS era. Scandinavian Journal of Infectious Diseases, 38 (3), 181−186.
1.1.
2005
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
1.1.
2004
Uuskula, A.; Raukas, E. (2004). Atypical genital herpes: Report of five cases. Scandinavian Journal of Infectious Diseases, 36 (1), 37−39.
1.1.
2004
Uuskula, A.; Nygard-Kibur, M.; Cowan, FM.; Mayaud, P.; French, RS.; Robinson, JNR.; Brown, DWG. (2004). The burden of infection with herpes simplex virus type 1 and type 2: Seroprevalence study in Estonia. Scandinavian Journal of Infectious Diseases, 36 (10), 727−732.
1.1.
2004
Uuskula, A.; McNutt, LA.; Dehovitz, J. (2004). Treatment of sexually transmitted diseases in Estonia - Consistency with the evidence-based medicine principles. Sexually Transmitted Diseases, 31 (10), 631−635.
1.1.
2004
Uuskula, A.; Nygard, JF.; Kibur-Nygard, M. (2004). Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & Aids, 15 (10), 662−668.
1.3.
2004
Uusküla, A. (2004). Sugulisel teel levivad infektsioonid ja nende ravi HIV-infektsiooni ennetuses. Eesti Arst, 83 (3), 186−191.
1.3.
2004
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2004). Eestlaste sündide aastaajalisusest. Akadeemia, 12, 2563−2589.
1.1.
2003
Cowan, FM.; French, RS.; Mayaud, P.; Gopal, R.; Robinson, NJ.; de Oliveira, SA.; Faillace, T.; Uuskula, A.; Nygard-Kibur, M.; Ramalingam, S.; Sridharan, G.; El Aouad, R.; Alami, K.; Rbai, M.; Sunil-Chandra, NP.; Brown, DW. (2003). Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sexually Transmitted Infections, 79 (4), 286−290.
3.3.
2003
Põder, A.; Maimets, M.; Silm, H.; Kangur, A.; Kukk, T.; Uusküla, A.; Rajangu, H. (2003). Seksuaalsel teel levivate infektsioonide ravijuhis Eestis. Tallinn: STLIEÜ.
1.1.
2002
Uuskula, A.; Kohl, PK. (2002). Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. International Journal of STD & Aids, 13 (2), 79−85.
1.2.
2002
Uusküla, A.; Kalikova, N.; Zilmer, K.; Tammai, L.; DeHovitz, J. (2002). The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases, 6 (1), 23−27.
3.1.
2002
Uusküla, A. (2002). Genital infection with Herpes simplex virus. Skin and Environment - Perception and Protection: 10th EADV Congress; Munich, Germany; October 10-14, 2001. _EditorsAbbr J.Ring, S.Weidinger, U.Darsow. Bologna: Monduzzi Editore, 321−328.
3.5.
2002
Uusküla, A. (2002). Uretriit - diagnostika ja ravi. Seksuaalsel Teel Levivate Infektsioonide Eesti Ühingu Toimetised: STLIEÜ IV aastakonverents; 14-15.juuni 2002; Palmse mõis. 49.
1.1.
2001
Uuskula, A.; Plank, T.; Lassus, A.; Bingham, JS. (2001). Sexually transmitted infections in Estonia - syndromic management of urethritis in a European country? International Journal of STD & Aids, 12 (8), 493−498.
1.1.
2001
Wilson, TE.; Uuskula, A.; Feldman, J.; Holman, S.; Dehovitz, J. (2001). A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia. Sexually Transmitted Diseases, 28 (11), 624−629.
3.3.
2001
Napritson, K.; Raudsepp, H.; Uusküla, A.; Kukk, T.; Kangur, A.; Karelson, M.; Lehtmets, A.; Rajangu, H.; Silm, H. (2001). Akne ravijuhend. Lege Artis (24−26).. Tallinn: Lege Artis.
1.3.
2000
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
6.6.
1999
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
1.1.
1997
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
10.01.2020

Anneli Uusküla

https://www.etis.ee/CV/Anneli_Uusküla/eng
11.04.1967
737 4195
anneli.uuskula@ut.ee
http://
H-3303-2015

Career

Institutions and positions
01.02.2018–...   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Professor (1,00)
2007–...   
University of Tartu, Faculty of Medicine, Professor (1,00)
2000–...   
Tartu University Hospital, Dermatology Clinic of Tartu University Hospital, Dermatovenerologist (0,25)
01.01.2016–31.01.2018   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Programme Director
01.01.2016–31.01.2018   
University of Tartu, Faculty of Medicine, Institute of Family Medicine and Public Health, Professor of Epidemiology (1,00)
01.02.2013–31.12.2015   
University of Tartu, Faculty of Medicine, Dean's Office, Programme Director
01.02.2013–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor of Epidemiology (1,00)
01.02.2008–31.01.2013   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor of Epidemiology (1,00)
01.02.2008–28.02.2009   
University of Tartu, Faculty of Medicine, Department of Public Health, Head of Institute
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Professor extraordinarius (0,50)
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Head of Institute
01.03.2007–31.01.2008   
University of Tartu, Faculty of Medicine, Department of Public Health, Senior Research Fellow (0,50)
01.02.2007–28.02.2007   
University of Tartu, Faculty of Medicine, Department of Public Health, Acting Head of Institute
2007–2009   
University of Tartu, Faculty of Medicine, Department of Public Health, Chair (0,25)
01.01.2005–28.01.2007   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Assistant (0,25)
01.05.2004–28.02.2007   
University of Tartu, Faculty of Medicine, Department of Public Health, Senior Research Fellow (0,75)
 
 
Education
2001–2003   
2001-2003 State University of New York, University at Albany, School of Public Health, MSc epidemiology
1997–2001   
1997-2001 Tartu University Medical Doctorancy (degree of Doctor of Medical Sciences)
1993–1997   
1993-1997 Tartu University Clinic of Dermatovenerology, Medical Residency in Dermatovenerology
1991–1993   
1991-1993 Tartu University Medical Internship [1993, Clinician, Department of Obstetrics and Gynecology; 1992, Clinician, Department of Internal Medicine; 1991, Clinician, Department of Surgery]
1958–1991   
1985-1991 Tartu University Medical Faculty
 
 
R&D related managerial and administrative work
2013−...   
Journal BMC infectious diseases, editor
2012−...   
Estonian Health Insurance Fund, Working group for treatment guidelines, member
2011−...   
Journal Eesti arst, scientific editor
2009−...   
Estonian research counsil, health area expert committee, member
2009−...   
European Center of Disease Control (ECDC), expert
2006−...   
Society of dermatovenerologists in Estonia (President), member of the Board since 2012
2005−...   
European Medicines Agency, EMEA, expert
2004−...   
Member of the Estonian governments' HIV/AIDS commision
1999−...   
State agency of medicines, expert (dermatology)
1997−...   
Member of New York Academy of Sciences
Expert commitees
2004−2008   
European Surveillance of Sexually Transmitted Infections (ESSTI), country representative
1999−2010   
Union against sexually transmitted infections in Estonia (member of board)
 
 
Additional information
COMPLETED RESEARCH GRANTS

National institutes of health (USA)/NIAID R01AI083035
06/2009-08/2014
PI - DesJarlais D (Beth Isreal Med Center, NY, USA)
Multiple Prevention Programs Project for IDUs in Eastern Europe (Estonia)

European Commission/ Leonardo da Vinci Programme
01/2013-12/2015
PI – McNulty C (HPA, UK)
Chlamydia Testing Training Into Europe (CaTTE)

European Centre for Disease Prevention and Control (ECDC)
01/2012-04/2014
PI – Low N (Univ Bern, Switzerland)
Chlamydia Control in Europe

Norwegian Financial Mechanism / EEA grant EE0016
11/2007 – 05/2011
PI – Uusküla A/Kiivet R
Capacity building for disease surveillance and health monitoring in Estonia

National institutes of health (USA) / FIC R01 TW06990-01
07/2004-07/2010
PI - Uuskula A
Homescreening for sexually transmitted infections in Estonia

Merck (USA) Investigator initiated research program MISP #38078
12/2010-12/2013
PI – Uusküla A (Univ Tartu)
The Burden of Genital Warts: a study from three Baltic countries

National institutes of health (USA) / NIDA R01 003574
09/2005 - 08/2010
PI - Des Jarlais DC
Risk Factors for AIDS among IV Drug Users

European Centre for Disease prevention and Control OJ/2008/04/11 – PROC/2008/006
06/2008-05/2010
PI – Low N
Evaluating the public health benefits of partner notification

Civilian Research & Development Foundation (USA) ESB1-7002-TR-08
10/2008 - 12/2010
PI – Uusküla A
HIV Transmission Among Injecting and Non-Injecting Drug Users in Tallinn, Estonia

Civilian Research & Development Foundation (USA) ESXO-002722-TA06
PI - Uusküla A
Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners.
02/2006-01/2008

;

Qualifications

Academic degrees
Anneli Uusküla, Research Master's Degree, 2003, (sup) Louise-Anne McNutt, Treatment of the sexually transmitted diseases in Estonia: consistency with the evidence based medicine principles, State University of New York at Albany, School of Public Health.
Anneli Uusküla, Doctor's Degree, 2001, (sup) Helgi Silm, Epidemiology of sexually transmitted diseases in Estonia in 1990 - 2000, University of Tartu, Faculty of Medicine.
 
 
Honours & awards
2001, Anneli Uusküla, NIH Fellowship, Fogarty International Center (State University of New York, School of Public Health, Albany, NY)
 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.6. Public Health Science
ETIS CLASSIFICATION: 3. Health; 3.7. Clinical Medicine
 
 

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

Category
Year
Publication
 
5.2.
2019
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade. Eesti Arst, 98: Tartu Ülikooli arstiteaduskonna aastapäeva teaduskoneverents 2019. Tartu: Celsius Healthcare , 32−32. (lisa 3).
5.2.
2019
Rooväli,L.; Pisarev,H.; Suija,K.; Uusküla,A.; Kiivet R-A. (2019). Understanding risk factors and warning signs for suicide. In: .
1.1.
2018
Tavitian-Exley, Isabel; Maheu-Giroux, Mathieu; Platt, Lucy; Heimer, Robert; Uusküla, Anneli; Levina, Olga; Vickerman, Peter; Boily, Marie-Claude (2018). Differences in risk behaviours and HIV status between primary amphetamines and opioid injectors in Estonia and Russia. The International journal on drug policy, 53, 96−105.10.1016/j.drugpo.2017.11.010.
1.1.
2018
Werb, Dan; Bluthenthal, R. N.; Kolla, G.; Strike, C.; Kral, A. H.; Uuskula, A.; Des Jarlais, D. (2018). Preventing Injection Drug use Initiation: State of the Evidence and Opportunities for the Future. Journal of Urban Health, 95 (1), 91−98.10.1007/s11524-017-0192-8.
1.1.
2018
Chan, Pui Y; Joseph, Michael A; Des Jarlais, Don C; Uusküla, Anneli (2018). Perceived effectiveness of antiretroviral therapy, self-rated health and treatment adherence among HIV-positive people who inject drugs in Estonia. International journal of STD & AIDS, 29 (1), 13−22.10.1177/0956462417714635.
1.1.
2018
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; HIV-BRIDGE Study Group (2018). Effects of Counselling on Adherence to Antiretroviral Treatment Among People with HIV in Estonia: A Randomized Controlled Trial. AIDS and Behavior, 22 (1), 224−233.10.1007/s10461-017-1859-6.
1.1.
2018
Jõgeda, E-L; Avi, R; Pauskar, M; Kallas, E; Karki, T; Des Jarlais, D; Uusküla, A; Toompere, K; Lutsar, I; Huik, K (2018). Association of IFNλ4 rs12979860 polymorphism with the acquisition of HCV and HIV infections among people who inject drugs. Journal of Medical Virology, 90 (11), 1779−1783.10.1002/jmv.25258.
1.1.
2018
Tavitian-Exley, Isabel; Boily, Marie-Claude; Heimer, Robert; Uuskula, Anneli; Levina, Olga; Maheu-Giroux, Mathieu (2018). Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis. AIDS and Behavior, 22 (4), 1329−1340.10.1007/s10461-017-1836-0.
1.1.
2018
Tisler-Sala, Anna; Ojavee, Sven-Erik; Uuskula, Anneli (2018). Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associated with non-compliant prescribing: findings form a cross-sectional study. Sexually Transmitted Infections, 94 (4), 297−302.10.1136/sextrans-2017-053247.
1.1.
2018
Kivimets, Kristel; Uuskula, Anneli; Lazarus, Jeffrey V.; Ott, Kristi (2018). Hepatitis C seropositivity among newly incarcerated prisoners in Estonia: data analysis of electronic health records from 2014 to 2015. BMC Infectious Diseases, 18, ARTN 339.10.1186/s12879-018-3242-2.
1.1.
2018
Uusküla, Anneli; Pisarev, Heti; Kurvits, Katrin; Laius, Ott; Laanpere, Made; Uusküla, Maia (2018). Compliance with Pregnancy Prevention Recommendations for Isotretinoin in Estonia in 2012-2016. Drugs - Real World Outcomes, 5 (2), 129−136.10.1007/s40801-018-0135-z.
1.1.
2018
Des Jarlais, Don C.; Arasteh, K.; Feelemyer, J.; McKnight, C.; Barnes, David M.; Perlman, David C.; Uuskula, A.; Cooper, H. L. F.; Tross, Susan (2018). Hepatitis C virus prevalence and estimated incidence among new injectors during the opioid epidemic in New York City, 2000-2017: Protective effects of non-injecting drug use. Drug and Alcohol Dependence, 192, 74−79.10.1016/j.drugalcdep.2018.07.034.
2.5.
2018
Rooväli, L.; Pisarev, H.; Suija, K.; Aksen, M.; Uusküla, A.; Kiivet; RA: (2018). Aastatel 2006–2016 enesetapu sooritanute epidemioloogiline ülevaade [Epidemiological study of committed suicides in 2006–2016 in Estonia].
5.2.
2018
Lemsalu L, Rice B, Uusküla A, Raag M, Lutsar I, Rüütel K (2018). How to ascertain an accurate number of people living with diagnosed HIV and fill data gaps from the past - lessons learned from a high prevalence setting in Europe. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society,.
5.2.
2018
Lemsalu L, Uusküla A, Rice B, Raag M, Rüütel K (2018). Drug overdose is the most common cause of death among HIV infected people in Estonia. 22nd International AIDS Conference, Amsterdam, the Netherlands, 23-27 July 2018. International AIDS Society,.
1.1.
2017
Johannson A, Vorobjov S, Heimer R, Dovidio JF, Uusküla A. (2017). The Role of Internalized Stigma in the Disclosure of Injecting Drug Use Among People Who Inject Drugs and Self-Report as HIV-Positive in Kohtla-Järve, Estonia. AIDS and Behavior, 21 (4), 1034−1043.10.1007/s10461-016-1647-8.
1.1.
2017
Anneli Uusküla, Mait Raag, Kristina Marsh, Ave Talu, Sigrid Vorobjov, Don Des Jarlais (2017). HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic. PLOS ONE, 12 (2), e0170956.10.1371/journal.pone.0170956.
1.1.
2017
Jogeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Karki, Tonis; Jarlais, Don Des; Uuskula, Anneli; Lutsar, Irja; Avi, Radko (2017). Prevalence and Genotypes of GBV-C and Its Associations With HIV Infection Among Persons Who Inject Drugs in Eastern Europe. Journal of Medical Virology, 89 (4), 632−638.10.1002/jmv.24683.
1.1.
2017
Wu, Jiacheng; Crawford, Forrest W; Raag, Mait; Heimer, Robert; Uusküla, Anneli (2017). Using data from respondent-driven sampling studies to estimate the number of people who inject drugs: Application to the Kohtla-Järve region of Estonia. PLoS ONE, 12 (11), e0185711−e0185711.10.1371/journal.pone.0185711.
1.1.
2017
Mikk Jürisson, Mait Raag, Riina Kallikorm, Margus Lember, Anneli Uusküla (2017). The impact of hip fracture on mortality in Estonia: a retrospective population-based cohort study. BMC Musculoskeletal Disorders, 18 (243), 1−10.10.1186/s12891-017-1606-1.
1.1.
2017
Võrno, Triin; Lutsar, Katrin; Uusküla, Anneli; Padrik, Lee; Raud, Terje; Reile, Rainer; Nahkur, Oliver; Kiivet, Raul-Allan (2017). Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage. Vaccine, 35 (46), 6329−6335.10.1016/j.vaccine.2017.08.083.
1.1.
2017
Heimer, Robert; Usacheva, Nina; Barbour, Russell; Niccolai, Linda M; Uusküla, Anneli; Levina, Olga S (2017). Engagement in HIV care and its correlates among people who inject drugs in St Petersburg, Russian Federation and Kohtla-Järve, Estonia. Addiction (Abingdon, England), 112 (8), 1421−1431.10.1111/add.13798.
1.1.
2017
McNulty C, Ricketts EJ, Fredlund H, Uusküla A, Town K, Rugman C, Tisler-Sala A, Mani A, Dunais B, Folkard K, Allison R, Touboul P. (2017). Qualitative interviews with healthcare staff in four European countries to inform adaptation of an intervention to increase chlamydia testing. BMJ Open, 7 (9), e017528.10.1136/bmjopen-2017-017528.
1.1.
2017
Wiessing, Lucas; Ferri, Marica; Běláčková, Vendula; Carrieri, Patrizia; Friedman, Samuel R; Folch, Cinta; Dolan, Kate; Galvin, Brian; Vickerman, Peter; Lazarus, Jeffrey V; Mravčík, Viktor; Kretzschmar, Mirjam; Sypsa, Vana; Sarasa-Renedo, Ana; Uusküla, Anneli; Paraskevis, Dimitrios; Mendão, Luis; Rossi, Diana; van Gelder, Nadine; Mitcheson, Luke ... Griffiths, Paul (2017). Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study. Harm reduction journal, 14 (1), 19−19.10.1186/s12954-017-0141-6.
1.1.
2017
Lemsalu, L.; Rüütel, K.; Laisaar, KT.; Lõhmus, L.; Raidvee, A.; Uusküla, A.; HIV-BRIDGE Study Group (2017). Suicidal Behavior Among People Living with HIV (PLHIV) in Medical Care in Estonia and Factors Associated with Receiving Psychological Treatment. AIDS Behav, 21 (6), 1709−1716.10.1007/s10461-016-1561-0.
5.2.
2017
Laisaar, Kaja-Triin; Raag, Mait; Lemsalu, Liis; Lõhmus, Liilia; Rüütel, Kristi; Amico, K. Rivet; Uusküla, Anneli; and the HIV-BRIDGE Study Group (2017). Patient characteristics to consider when supporting antiretroviral therapy adherence in people living with HIV: a randomized controlled trial in Estonia. Conference Abstract Book: 12th International Conference on HIV Treatment and Prevention Adherence (ADHERENCE 2017); Miami, FL, USA: 04.-06.06.2017. International Association of Providers of AIDS Care (IAPAC), 84−84.
1.1.
2016
Huik, Kristi; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Jõgeda, Ene-Ly; Karki, Tõnis; Rüütel, Kristi; Talu, Ave; Abel-Ollo, Katri; Uusküla, Anneli; Carrillo, Andrew; Ahuja, Sunil K; He, Weijing; Lutsar, Irja (2016). A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs. PLOS ONE, 11 (6), e0156850−e0156850.10.1371/journal.pone.0156850.
1.1.
2016
van den Broek, Ingrid V.; Sfetcu, Otilia; van der Sande, Marianne A.; Andersen, Berit; Herrmann, Björn; Ward, Helen; Götz, Hannelore M.; Uusküla, Anneli; Woodhall, Sarah C.; Redmond, Shelagh M.; Amato-Gauci, Andrew J.; Low, Nicola; van Bergen, Jan E. (2016). Changes in chlamydia control activities in Europe between 2007 and 2012: a cross-national survey. European journal of public health, 26 (3), 382−388.10.1093/eurpub/ckv196.
1.1.
2016
Calabrese, Sarah K.; Burke, Sara E.; Dovidio, John F.; Levina, Olga S.; Uusküla, Anneli; Niccolai, Linda M.; Heimer, Robert (2016). Internalized HIV and Drug Stigmas: Interacting Forces Threatening Health Status and Health Service Utilization Among People with HIV Who Inject Drugs in St. Petersburg, Russia. AIDS and behavior, 20 (1), 85−97.10.1007/s10461-015-1100-4.
1.1.
2016
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2016). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 2016 (9), Article number CD010866.10.1002/14651858.CD010866.pub2.
1.1.
2016
Jürisson, Mikk; Pisarev, Heti; Kanis, John; Borgström, Fredrik; Svedbom, Axel; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli (2016). Quality of life, resource use, and costs related to hip fracture in Estonia. Osteoporosis International, 27 (8), 2555−2566.10.1007/s00198-016-3544-4.
1.1.
2016
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). Differences in T cell distribution and CCR5 expression in HIV-positive and HIV-exposed seronegative persons who inject drugs. Medical microbiology and immunology, 205 (3), 231−239.10.1007/s00430-015-0444-8.
1.1.
2016
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi (2016). Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe. Infection, Genetics and Evolution, 43, 83−85.10.1016/j.meegid.2016.05.022.
1.1.
2016
Kallas, Eveli; Huik, Kristi; Türk, Silver; Pauskar, Merit; Jõgeda, Ene-Ly; Šunina, Marina; Karki, Tõnis; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja (2016). T Cell Distribution in Relation to HIV/HBV/HCV Coinfections and Intravenous Drug Use. Viral immunology, 0−0.vim.2016.0057.
1.1.
2016
Laisaar, K.T.; Raag, M.; Lutsar, I.; Uusküla, A. (2016). People living with HIV in Estonia: engagement in HIV care in 2013. Eurosurveillance, 21 (43), x−x.10.2807/1560-7917.ES.2016.21.43.30380.
5.2.
2016
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, KT., Uusküla, A., for OptTEST by HIV in Europe (2016). Changes in quality of life of PLHIV in Estonia from 2005 to 2013. 21st International AIDS Conference, Durban, South Africa, July 18-22, 2016. International AIDS Society, 143.
1.1.
2015
Uusküla, Anneli; Reile, Rainer; Rezeberga, Dace; Karnite, Anda; Logminiene, Zenetha; Padaiga, Zilvinas; Nygård, Mari. (2015). The prevalence of genital warts in the Baltic countries: findings from national cross-sectional surveys in Estonia, Latvia and Lithuania. Sexually Transmitted Infections, 91 (1), 55−60.10.1136/sextrans-2014-051540.
1.1.
2015
Shelagh M. Redmond, Karin Alexander-Kisslig, Sarah C. Woodhall, Ingrid V. F. van den Broek, Jan van Bergen, Helen Ward, Anneli Uusküla, Björn Herrmann, Berit Andersen, Hannelore M. Götz, Otilia Sfetcu, Nicola Low (2015). Genital Chlamydia prevalence in europe and non-European high income countries: systematic review and meta-analysis. PLoS ONE, 10 (1), e0115753.10.1371/journal.pone.0115753.
1.1.
2015
Uusküla, A.; Erm, T. (2015). Disseminated Giant Hyperkeratotic Porokeratosis and Treatment with Acitretin: A Case Report. Acta Dermato-Venereologica, 95 (2), 241−242.10.2340/00015555-1908.
1.1.
2015
Feelemyer, J.; Des Jarlais, D.; Arasteh, K.; Uusküla, A. (2015). Adherence to Antiretroviral Medications Among Persons Who Inject Drugs in Transitional, Low and Middle Income Countries: An International Systematic Review. AIDS and Behavior, 19 (4), 575−583.10.1007/s10461-014-0928-3.
1.1.
2015
Perlman DC, Jordan AE, Uuskula A, Huong DT, Masson CL, Schackman BR, Des Jarlais DC. (2015). An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential. International Journal of Drug Policy, S0955-3959(15)00126-7.
1.1.
2015
Uusküla, A.; Des Jarlais, D.C.; Raag, M.; Pinkerton, S.D.; Feelemyer, J. (2015). Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia. AIDS care, 27 (1), 105−11.10.1080/09540121.2014.940271.
1.1.
2015
Jürisson, Mikk; Vorobjov, Sigrid; Kallikorm, Riina; Lember, Margus; Uusküla, Anneli. (2015). The incidence of hip fractures in Estonia, 2005–2012. Osteoporosis International, 26 (1), 77−84.10.1007/s00198-014-2820-4.
1.1.
2015
Morozova, Olga; Levina, Olga; Uusküla, Anneli; Heimer, Robert (2015). Comparison of subset selection methods in linear regression in the context of health-related quality of life and substance abuse in Russia. BMC medical research methodology, 15 (71), 71−71.10.1186/s12874-015-0066-2.
1.1.
2015
Burke, Sara E; Calabrese, Sarah K; Dovidio, John F; Levina, Olga S; Uusküla, Anneli; Niccolai, Linda M; Abel-Ollo, Katri; Heimer, Robert (2015). A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social science & medicine (1982), 130, 154−161.10.1016/j.socscimed.2015.02.018.
1.1.
2015
Laisaar, Kaja-Triin; Raag, Mait; Rosenthal, Marika; Uusküla, Anneli (2015). Behavioral Interventions to Reduce Sexual Risk Behavior in Adults with HIV/AIDS Receiving HIV Care: A Systematic Review. AIDS Patient Care and STDs, 29 (5), 288−289.10.1089/apc.2014.0240.
1.1.
2015
Uuskuela, Anneli; Raag, Mait; Vorobjov, Sigrid; Rueuetel, Kristi; Lyubimova, Alexandra; Levina, Olga S.; Heimer, Robert (2015). Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Jarve, Estonia. BMC Public Health, 15, ARTN 1255.10.1186/s12889-015-2604-6.
1.1.
2015
Uusküla, A.; Toompere, K.; Laisaar, KT.; Rosenthal, M.; Pürjer, ML.; Knellwolf, A.; Läärä, E.; Des Jarlais, DC. (2015). HIV research productivity and structural factors associated with HIV research output in European Union countries: a bibliometric analysis. BMJ Open, 5 (2), e006591−8.10.1136/bmjopen-2014-006591.
2.5.
2015
Jürisson, Mikk; Taba, Pille; Võrno, Triin; Abram, Mikk; Eiche, Ivar-Endrik; Uusküla, Anneli (2015). Puukentsefaliidivastase vaktsineerimise kulutõhusus Eestis. Tartu: Tartu Ülikooli tervishoiu instituut.
5.2.
2015
Jõgeda, Ene-Ly; Avi, Radko; Pauskar, Merit; Kallas, Eveli; Karki, Tõnis; Jarlais, Don Des; Uusküla, Anneli; Lutsar, Irja; Huik, Kristi; (2015). HTLV-1/2 is rare among Eastern-European intravenous drug users (IDUs). Retrovirology, 12, P79−P79.10.1186/1742-4690-12-S1-P79.
5.2.
2015
Laisaar, K.T., Raag, M., Rüütel, K., Lemsalu, L., Lõhmus, L., Uusküla, A. (2015). Measuring Antiretroviral Therapy Adherence in Clinical Care Settings in Estonia. 10th International Conference on HIV Treatment and Prevention Adherence, Miami, USA, June 28-30 2015. International Association of Providers of AIDS Care, 103.
1.1.
2014
Kivimets K, Uuskula A. (2014). HIV testing and counselling in Estonian prisons, 2012 to 2013: aims, processes and impacts. Eurosurveillance, 19 (47), 31−37.
1.1.
2014
Uusküla A, Ricketts EJ, Rugman C, Kalda RR, Fredlund H, Hedlund J, Dunais B, Touboul PP, McNulty C (2014). Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries. BMC Public Health, 14, 1147.10.1186/1471-2458-14-1147.
1.1.
2014
DeHovitz, J.; Uuskula, A.; El-Bassel, N. (2014). The HIV epidemic in Eastern Europe and Central Asia. Current HIV/AIDS Reports, 11 (2), 168−176.10.1007/s11904-014-0202-3.
1.1.
2014
Burke, S.E.; Calabrese, S.K.; Dovidio, J.F.; Levina, O.S.; Uusküla, A.; Niccolai, L.M.; Abel-Ollo, K.; Heimer, R. (2014). A tale of two cities: stigma and health outcomes among people with HIV who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia. Social science and medicine, 130, 154−162.10.1016/j.socscimed.2015.02.018.
1.1.
2014
Huik, K.; Avi, R.; Uibopuu, H.; Pauskar, M.; Margus, T.; Karki, T.; Krispin, T.; Kool, P.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Carrillo, AQ.; He, W.; Ahuja, SK.; Lutsar, I. (2014). Association between HIV-1 tropism and CCR5 human haplotype E in a Caucasian population. Jaids-Journal of Acquired Immune Deficiency Syndromes, 66 (3), 239−244.10.1097/QAI.0000000000000127.
1.1.
2014
Rüütel, Kristi; Karnite, Anda; Talu, Ave; Abel-Ollo, Katri; Kirvelaite, Gunta; Kliiman, Kai; Loit, Helle-Mai; Uusküla, Anneli. (2014). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy, 25 (1), 175−178.10.1016/j.drugpo.2013.10.002.
1.1.
2014
Rahu, K.; Bromet, E. J.; Hakulinen, T.; Auvinen, A.; Uusküla, A.; Rahu, M. (2014). Non-cancer morbidity among Estonian Chernobyl cleanup workers: a register-based cohort study. BMJ Open, 4, e004516.10.1136/bmjopen-2013-004516.
1.1.
2014
Uusküla, A.; Raag, M.; Folch, C.; Prasad, L.; Karnite, A.; van Veen, M.G.; Eritsyan, K.; Rosinska, M.; Des Jarlais, D.C.; Wiessing, L. (2014). Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West. AIDS, 28 (11), 1657−64.10.1097/QAD.0000000000000299.
2.5.
2014
Männik, Agnes; Suuroja, Tiit; Juus, Eva; Võrno, Triin; Uusküla, Anneli; Reile, Rainer; Orav, Kateriine; Kiivet, Raul-Allan (2014). Kolorektaalvähi sõeluringu kulutõhusus. 1−113.
2.5.
2014
Lõhmus, L.; Lemsalu, L.; Rüütel, K.; Laisaar, K.-T.; Uusküla, A. (2014). Infektsionisti külastavate HIV-i nakatunud inimeste tervis. 2013. aasta terviseuuringu raport.
3.4.
2014
Laisaar, Kaja-Triin; Raag, Mait; Rasva, Heli; Uusküla, Anneli (2014). Engagement in the continuum of HIV care in Estonia. 337.
5.2.
2014
Lemsalu, L., Rüütel, K., Lõhmus, L., Laisaar, K-T., Uusküla, A. (2014). Suicidality is common among HIV infected people in Estonia and is associated with lack of psychological help. 15th European Symposium on Suicide and Suicidal Behaviour, Tallinn, Estonia, 27-30.08.2014. European Symposium on Suicide and Suicidal Behaviour, 280.
1.1.
2013
Liivlaid, H; Uusküla, A (2013). Changes in high-risk sexual behaviour among Estonian adults between 1996 and 2006. Sexually Transmitted Infections, 89 (2), 91−97.10.1136/sextrans-2012-050506.
1.1.
2013
Karnite, A.; Brigis, G.; Uusküla, A. (2013). Years of potential life lost due to HIV infection and associated factors based on national HIV surveillance data in Latvia, 1991-2010. Scandinavian Journal of Infectious Diseases, 45 (2), 140−146.10.3109/00365548.2012.717710.
1.1.
2013
Vickerman, P; Martin, NK; Roy, A; Beattie, T; EMCDDA Collaborative Group, Jarlais, DD; Strathdee, S; Wiessing, L; Hickman, M (2013). Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission? Drug and Alcohol Dependence, 132, 172−182.10.1016/j.drugalcdep.2013.01.020.
1.1.
2013
Laisaar, KT; Uusküla, A; Sharma, A; DeHovitz, JA; Amico, KR (2013). Developing an adherence support intervention for patients on antiretroviral therapy in the context of the recent IDU-driven HIV/AIDS epidemic in Estonia. AIDS care, 25 (7), 863−873.10.1080/09540121.2013.764393.
1.1.
2013
Huik, K; Avi, R; Pauskar, M; Kallas, E; Jõgeda, EL; Karki, T; Marsh, K; Des Jarlais, D; Uusküla, A; Lutsar, I (2013). Association between TLR3 rs3775291 and resistance to HIV among highly exposed Caucasian intravenous drug users. Infection, Genetics and Evolution, 20, 78−82.10.1016/j.meegid.2013.08.008.
1.1.
2013
Huik, K; Avi, R; Carrillo, A; Harper, N; Pauskar, M; Sadam, M; Karki, T; Krispin, T; He, W; Lutsar, I (2013). CCR5 Haplotypes Influence HCV Serostatus in Caucasian Intravenous Drug Users. PLoS ONE, 8 (7), e70561.10.1371/journal.pone.0070561.
1.1.
2013
Uusküla, Anneli; Rajaleid, Kristiina; Talu, Ave; Abel-Ollo, Katri; Des Jarlais, Don (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal of Drug Policy, 24 (4), 312−318.10.1016/j.drugpo.2012.11.002.
1.1.
2013
Vorobjov, S; Des Jarlais, DC; Abel-Ollo, K; Talu, A; Rüütel, K; Uusküla, A (2013). Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: Evidence from cross-sectional surveys. International Journal of Drug Policy, 24 (2), 150−155.10.1016/j.drugpo.2012.08.003.
1.1.
2013
Puur, A., Altmets, K., Saava, A., Uusküla, A., Sakkeus, L. (2013). Non-fatal injuries resulting in activity limitations in Estonia: risk factors and association with the incidence of chronic conditions and quality of life. A retrospective study among the population aged 20-79. BMJ Open, 3, 1−7.10.1136/bmjopen-2013-002695.
1.1.
2013
Anneli Uusküla, A.; Müürsepp, A.; Kawai, K.; Raag, M.; Jürisson, M.; Pillsbury, M. (2013). The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia. BMC Infectious Diseases, 13, No 304.10.1186/1471-2334-13-304.
1.1.
2013
Uusküla, A.; Raag, M.; Uppin, A.; Raud, T.; Klaar, U.; Jürisson, M.; Müürsepp, A. (2013). Incidence of Cervical Intraepithelial Neoplasia in Estonia. Journal of Lower Genital Tract Disease, 17 (2), 129−136.10.1097/LGT.0b013e3182652213.
1.2.
2013
Low, N.; Redmond, S.; Uusküla, A.; van Bergen, J.; Ward, H.; Andersen, B.; Götz, H. (2013). Screening for genital chlamydia infection. Cochrane Database of Systematic Reviews, 12, x−x.10.1002/14651858.CD010866.
1.2.
2013
Des Jarlais DC, Pinkerton S, Hagan H, Guardino V, Feelemyer J, Cooper H, Hatzatkis A, Uuskula A. (2013). 30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs. Advances in Preventive Medicine, 2012, 346372.
1.3.
2013
Anderson, Eva; Toompere, Karolin; Reile, Rainer; Uusküla, Anneli (2013). Naiste teadlikkus emakakaelavähki ennetavatest meetmetest Eestis 2011. aastal. Eesti Arst, 92 (4), 195−203.
1.3.
2013
Uusküla, A (2013). Ajas muutuvad eesmärgid. Eesti Arst, 92 (5), 244−246.
5.2.
2013
Jõgeda, Ene-Ly; Huik, Kristi; Pauskar, Merit; Kallas, Eveli; Krispin, Tõnu; Karki, Tõnis; Marsh, Kristina; Des Jarlais, Don; Uusküla, Anneli; Avi, Radko; Lutsar, Irja. (2013). The prevalence of GBV-C and its associations with HIV infection among Estonian intravenous drug users. Reviews in Antiviral Therapy Infectious Diseases: 11th European Meeting on HIV & Hepatitis- Treatment Strategies & Antiviral Drug Resistance; Rome; 20-22 March 2013. 46−47.
5.2.
2013
Raag, Mait; Uusküla, Anneli; Des Jarlais, Don; Wiessing, Lucas (2013). Relationship between risk behaviour and awareness of HIV status among injecting drug users: a multisite study. European Journal of Epidemiology, 28: European Congress on Epidemiology 2013, Aarhus, Taani, 2013. Springer, S195−S196.10.1007/s10654-013-9820-0.
1.1.
2012
Uusküla, A.; Laisaar, K.-T.; Raag, M.; Smidt, J.; Semjonova, S.; Kogan, J.; Amico K, R.; Sharma, A.; Dehovitz , J. (2012). Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS care, 24 (12), 1470−1479.10.1080/09540121.2012.672724.
1.1.
2012
Vorobjov S, Uusküla A, Des Jarlais DC, Abel-Ollo K, Talu A, Rüütel K. (2012). Multiple routes of drug administration and HIV risk among injecting drug users. The Journal of Substance Abuse Treatment, 42 (4), 413−420.
5.1.
2012
Uusküla, Anneli; Laisaar, Kaja-Triin; Raag, Mait; Šmidt, Jelena; Semjonova, Svetlana; Kogan, Juta; Amico, K. Rivet; Sharma, Anjali; DeHovitz, Jack (2012). Antiretroviral therapy (ART) adherence and correlates to non-adherence among people on ART in Estonia. Retrovirology: 17th International Symposium on HIV and Emerging Infectious Diseases (ISHEID); 23-25 May 2012; Marseille, France. Biomed Central Ltd, P80. (9(Suppl 1)).10.1186/1742-4690-9-S1-P80.
5.2.
2012
Uibopuu, H.; Huik, K.; Avi, R.; Pauskar, M.; Kallas, E.; Karki, T.; Krispin, T.; Kool, P.; Schmidt, J.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Uusküla, A.; Lutsar, I. (2012). Viral tropism of HIV-1 CRF06_cpx and its association with CCR5 haplotypes. 10th European Meeting on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 28 - 30 March 2012 Barcelona Spain.
1.1.
2011
Uusküla, A.; Abel-Ollo, K.; Markina, A.; McNutt, LA.; Heimer, R. (2011). Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia. Sexually Transmitted Infections, 88 (1), 58−62.10.1136/sextrans-2011-050195.
1.1.
2011
Uusküla, A.; Kals, M; McNutt, LA. (2011). Assessing non-response to a mailed health survey including self-collection of biological material. European Journal of Public Health, 21 (4), 538−542.10.1093/eurpub/ckq053.
1.1.
2011
Laisaar, K.-T.; Avi, R.; Dehovitz, J.; Uusküla, A. (2011). Estonia at the Threshold of the Fourth Decade of the AIDS Era in Europe. Aids Research and Human Retroviruses, 27 (8), 841−851.10.1089/aid.2010.0223.
1.1.
2011
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 30 (11), 517.10.1186/1471-2458-11-517.
1.1.
2011
Altmets, K.; Puur, A. ; Uusküla, A.; Saava, A.; Sakkeus, L.; Katus, K. (2011). Self-reported activity limitations among the population aged 20-79 in Estonia: a cross-sectional study. European Journal of Public Health, 21 (1), 49−55.10.1093/eurpub/ckp239.
1.2.
2011
Rüütel, Kristi; Loit, Helle-Mai; Sepp, Tiiu; Kliiman, Kai; McNutt, Louise-Anne; Uusküla, Anneli. (2011). Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Research Notes, 192.
1.3.
2011
Uusküla, A. (2011). KONSTANDID NÕUAVAD TÄHELEPANU. Akadeemia, 1, 144−152.
1.3.
2011
Saava, Astrid;Puur, Allan;Altmets, Katre;Sakkeus, Luule;Uusküla, Anneli (2011). Toimetulekupiiranguid põhjustanud vigastused Eestis: rahvastikupõhine sündmuslooline uuring. Eesti Arst, 90, 4, 165−173.
2.5.
2011
Briljene, T.; Haldre, K.; Karro, H.; Konno, P.; Kukk, T.; Maimets, M.; Punab, M.; Põder, A.; Silm, H.; Szirko, F.; Sõritsa, A.; Zilmer, K.; Tamm, T.; Tammemäe, L.; Timberg, G.; Uusküla, A. (2011). Seksuaalsel teel levivate infektsioonide ravijuhised Eestis.
2.5.
2011
Liiv, Kristi; Lutsar, Katrin; Palm, Eva; Uusküla, Anneli; Kiivet, Raul-Allan (2011). Inimese papilloomiviiruse vastaste vaktsiinide kulutõhusus Eestis. Tartu: Tartu Ülikool, tervishoiu instituut.
3.2.
2011
Lioznov D, Rüütel K, Uusküla A, DeHovitz J (2011). AIDS in Eastern Europe and Central Asia. In: Hall JC, Hall BJ, Cockerell CJ (_EditorsAbbr). HIV/AIDS IN THE POST-HAART ERA: Manifestations, Treatment & Epidemiology (820).. P. Lang.
1.1.
2010
Uusküla, A.; Kals, M.; Kosenkranius, L.; McNutt, LA.; DeHovitz, JJ. (2010). Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia. BMC Infectious Diseases, 10, Article Number: 63.10.1186/1471-2334-10-63.
1.1.
2010
Uusküla, A.; McMahon, JM.; Raag, M.; Silm, S.; Rüütel, K.; Talu, A.; Abel-Ollo, K.; Ahas, R.; Des Jarlais, DC. (2010). Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors. Sexually Transmitted Infections, 86, 3, 79−84.
1.1.
2010
Uusküla, A.; Johnston, L.G.; Raag, M.; Trummal, A.; Talu, A.; Des Jarlais, D.C. (2010). Evaluating recruitment among female sex workers and injecting drug users at risk for HIV using respondent driven sampling in Estonia. Journal of Urban Health, 87 (2), 304−317.10.1007/s11524-009-9427-7.
1.1.
2010
Talu, A.; Rajaleid, K.; Abel-Ollo, K.; Rüütel, K.; Rahu, M.; Rhodes, T.; Platt, L.; Bobrova, N.; Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: Implications for intervention. International Journal of Drug Policy, 21 (1), 56−63.10.1016/j.drugpo.2009.02.007.
1.1.
2010
Huik, K.; Sadam, M.; Karki, T.; Avi, R.; Krispin, T.; Paap, P.; Rüütel, K.; Uusküla, A.; Talu, A.; Abel-Ollo, K.; Lutsar, I. (2010). CCL3L1 copy number is a strong genetic determinant of HIV seropositivity in Caucasian intravenous drug users. The Journal of Infectious Diseases, 730−739.
1.1.
2010
Uusküla A, Puur A, Toompere K, DeHovitz J. (2010). Trends in the epidemiology of bacterial sexually transmitted infections in Eastern Europe, 1995-2005: review. Sexually Transmitted Infections, 86, 6−14.10.1136/sti2009.037044.
5.1.
2010
Laisaar, Kaja-Triin; Uusküla, Anneli, Sharma, Anjali; DeHovitz, Jack (2010). Services integration for injection drug users on antiretroviral therapy for management of HIV epidemic in Estonia. Retrovirology: 16th International Symposium on HIV and Emerging Infectious Diseases; 24-26 March 2010; Marseille, France. Biomed Central Ltd, P142. (7(Suppl 1)).10.1186/1742-4690-7-S1-P142.
1.1.
2009
McNutt, L.A.; Gordon, EJ; Uuskula, A. (2009). Informed recruitment in partner studies of HIV transmission: an ethical issue in couples research. BMC Medical Ethics, 10, 14.
1.1.
2009
Vorobjov, S.; Uusküla, A.; Abel-Ollo, K.; Talu, A.; Des Jarlais, D. (2009). Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia. Journal of Urban Health, 86 (6), 918−928.
1.1.
2009
Abel-Ollo, K.; Rahu, M.; Rajaleid, K.; Talu, A.; Rüütel, K.; Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A. (2009). Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS care, 21 (7), 851−857.
1.1.
2009
Vorobjov, S.; Uuskula, A.; Abel-Ollo, K.; Talu, A.; Ruutel, K.; Des Jarlais, D.C. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm reduction journal, 6 (1), 3.
1.2.
2009
Paat, G. ; Uusküla, A.; Tefanova, V.; Tallo, T.;Priimägi, L.;Ahi, K. (2009). The trends and risk factors for hepatitis B occurrence in Estonia. Central European Journal of Public Health, 17, 108−111.
1.2.
2009
Rüütel, K, Pisarev, H, Loit, HM, Uusküla, A. (2009). Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey. Journal of the International AIDS Society, 12, 13.
1.3.
2009
Uusküla, A.; Jürisson, M.; Võrk, A.; Kallikorm, R. (2009). Sõeluuringu rakendamise põhjendatus osteoporoosi varaseks diagnoosimiseks Eestis. Eesti Arst, 402−413.
1.1.
2008
Uusküla, A.; Fischer, K.; Raudne, R.; Kilgi, H.; Krylov, R.; Salminen, M.; Brummer-Korvenkontio, H.; St Lawrence, J.; Aral, S. (2008). A study on HIV and hepatitis C virus among commercial sex workers in Tallinn. Sexually Transmitted Infections, 84 (3), 189−191.10.1136/sti.2007.027664.
1.1.
2008
Uusküla, A.; Kals, M.; Denks, K.; Nurm, U.; Kasesalu, L.; Dehovitz, J.; McNutt, L.A. (2008). The prevalence of chlamydial infection in Estonia: a poplation-based survey. International Journal of STD & Aids, 19 (7), 455−458.10.1258/ijsa.2008.007325.
1.1.
2008
Uusküla, A.; Kals, M.; Rajaleid, K.; Abel, K.; Talu, A.; Rüütel, K.; Platt, L.; Rhodes, T.; Dehovitz, J.; Des Jarlais, D. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs. Journal of Public Health, 30 (2), 119−125.10.1093/pubmed/fdn014.
1.2.
2008
Rüütel K, Uusküla A, Minossenko A, Loit HM (2008). Quality of life of people living with HIV and AIDS in Estonia. Central European Journal of Public Health, 16 (3), 111−115.
1.3.
2008
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Toimetulekupiirangud Eesti täisealises rahvastikus - levimus ja tegelik abistamine. Eesti Arst, 87 (2), 92−101.
3.2.
2008
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2008). Seasonal variability of human reproduction in Estonia. In: Roosaare, J.; Mander, Ü. (_EditorsAbbr). Estonia. Geographical Studies (19−41).. Tartu: Tartu Ülikooli Kirjastus. (Publicationes Instituti Geographici Universitatis Tartuensis; 107).
5.1.
2008
Altmets, K.; Katus, K.; Puur, A.; Saava, A.; Uusküla, A. (2008). Activity limitations among adult population: evidence of Estonian family and fertility survey. European Population Conference 2008. Programme and Abstracts: European Population Conference 2008. Migration and Migrants in Europe; Barcelona, Spain; 9-12.07.2008. European Association for Population Studies in association with Centre d`Estudis Demogràfics, 355−355.
5.2.
2008
Sadam, M.; Karki, T.; Huik, K.; Avi, R.; Rüütel, K.; Uusküla, A.; Lutsar, I (2008). CCL3L1 Variable Gene Copy Number Influence on the Susceptibility to HIV-1/AIDS Among Estonian Intravenous Drug User. The 15th Conference on Retroviruses and Opportunistic Infections (CROI), Boston, 03.02-06.02.2008.
1.1.
2007
Uusküla, A.; McNutt, L.A.; Dehovitz, J.; Fischer, K.; Heimer, R. (2007). High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. International Journal of STD & Aids, 18 (1), 41−46.
1.1.
2007
Wilson, T.E.; Sharma, A.; Zilmer, K.; Kalikova, N.; Uusküla, A. (2007). The HIV prevention needs of injection drug users in Estonia. International Journal of STD & Aids, 18 (6), 389−391.
1.1.
2007
Uusküla, A.; Rajaleid, K.; Talu, A.; Abel, K.; Rüütel, K.; Hay, G. (2007). Estimating injection drug use prevalence using state wide administrative data sources: Estonia, 2004. Addiction Research and Theory, 15 (4), 411−424.
1.3.
2007
Kangur, A.; Põder, A.; Maimets, M.; Silm, H.; Kukk, T.; Uusküla, A.; Rajangu, H.; Brilene, T.; Zilmer, K.; Saarma, I.; Karro, H.; Tammemäe, L.; Szirko, F.; Timberg, G.; Punab, M.; Kallikorm, R. (2007). Seksuaalsel teel levivate infektsioonide Eesti ravijuhend 2007. I. Omandatud süüfilis. Eesti Arst, 86 (10), 770−777.
5.2.
2007
Altmets K., Katus K., Puur A., Saava A., Uusküla A. (2007). Toimetulekupiirangute levimus Eesti täisealises rahvastikus. Eesti Arst, 86. Eesti Arst, 679−680. (9).
1.1.
2006
Uuskula, A.; Heimer, R.; DeHovitz, J.; Fischer, K.; McNutt, LA. (2006). Surveillance of HIV, hepatitis B virus, and hepatitis c virus in an Estonian injection drug-using population: Sensitivity and specificity of testing syringes for public health surveillance. Journal of Infectious Diseases, 193 (3), 455−457.
1.1.
2006
Aral, S.O.; St Lawrence, J.S.; Uusküla, A. (2006). Sex Work in Tallinn, Estonia: The Socio-spatial Penetration of Sex Work into Society. Sexually Transmitted Infections, 82 (5), 348−353.
1.1.
2006
Platt, L.; Bobrova, N.; Rhodes, T.; Uusküla, A.; Parry, JV.; Rüütel, K.; Talu, A.; Abel, K.; Rajaleid, K.; Judd, A. (2006). High HIV prevalence among injecting drug users in Estonia: implications for understanding the risk environment. AIDS, 20 (16), 2120−2123.
1.1.
2006
Uuskula, A.; Kangur, K.; McNutt, L.A. (2006). Barriers to effective STI screening in a post-Soviet society: results from a qualitative study. Sexually Transmitted Infections, 82 (4), 323−326.
1.1.
2006
Rüütel, K.; Uusküla, A. (2006). HIV epidemic in Estonia in the third decade of AIDS era. Scandinavian Journal of Infectious Diseases, 38 (3), 181−186.
1.1.
2005
Naaber, P.; Uuskula, A.; Naaber, J.; Poder, A.; Hjelm, E.; Hallen, A.; Unemo, M.; Domeika, M. (2005). Laboratory diagnosis of sexually transmitted infections in Estonia in 2001-2002: Shortcomings with impact on diagnostic quality and surveillance. Sexually Transmitted Diseases, 32 (12), 759−764.
1.1.
2004
Uuskula, A.; Raukas, E. (2004). Atypical genital herpes: Report of five cases. Scandinavian Journal of Infectious Diseases, 36 (1), 37−39.
1.1.
2004
Uuskula, A.; Nygard-Kibur, M.; Cowan, FM.; Mayaud, P.; French, RS.; Robinson, JNR.; Brown, DWG. (2004). The burden of infection with herpes simplex virus type 1 and type 2: Seroprevalence study in Estonia. Scandinavian Journal of Infectious Diseases, 36 (10), 727−732.
1.1.
2004
Uuskula, A.; McNutt, LA.; Dehovitz, J. (2004). Treatment of sexually transmitted diseases in Estonia - Consistency with the evidence-based medicine principles. Sexually Transmitted Diseases, 31 (10), 631−635.
1.1.
2004
Uuskula, A.; Nygard, JF.; Kibur-Nygard, M. (2004). Syphilis as a social disease: experience from the post-communist transition period in Estonia. International Journal of STD & Aids, 15 (10), 662−668.
1.3.
2004
Uusküla, A. (2004). Sugulisel teel levivad infektsioonid ja nende ravi HIV-infektsiooni ennetuses. Eesti Arst, 83 (3), 186−191.
1.3.
2004
Ahas, R.; Roosaare, J.; Uusküla, A.; Silm, S. (2004). Eestlaste sündide aastaajalisusest. Akadeemia, 12, 2563−2589.
1.1.
2003
Cowan, FM.; French, RS.; Mayaud, P.; Gopal, R.; Robinson, NJ.; de Oliveira, SA.; Faillace, T.; Uuskula, A.; Nygard-Kibur, M.; Ramalingam, S.; Sridharan, G.; El Aouad, R.; Alami, K.; Rbai, M.; Sunil-Chandra, NP.; Brown, DW. (2003). Seroepidemiological study of herpes simplex virus types 1 and 2 in Brazil, Estonia, India, Morocco, and Sri Lanka. Sexually Transmitted Infections, 79 (4), 286−290.
3.3.
2003
Põder, A.; Maimets, M.; Silm, H.; Kangur, A.; Kukk, T.; Uusküla, A.; Rajangu, H. (2003). Seksuaalsel teel levivate infektsioonide ravijuhis Eestis. Tallinn: STLIEÜ.
1.1.
2002
Uuskula, A.; Kohl, PK. (2002). Genital mycoplasmas, including Mycoplasma genitalium, as sexually transmitted agents. International Journal of STD & Aids, 13 (2), 79−85.
1.2.
2002
Uusküla, A.; Kalikova, N.; Zilmer, K.; Tammai, L.; DeHovitz, J. (2002). The role of injecting drug use in the emergence of HIV in Estonia. International Journal of Infectious Diseases, 6 (1), 23−27.
3.1.
2002
Uusküla, A. (2002). Genital infection with Herpes simplex virus. Skin and Environment - Perception and Protection: 10th EADV Congress; Munich, Germany; October 10-14, 2001. _EditorsAbbr J.Ring, S.Weidinger, U.Darsow. Bologna: Monduzzi Editore, 321−328.
3.5.
2002
Uusküla, A. (2002). Uretriit - diagnostika ja ravi. Seksuaalsel Teel Levivate Infektsioonide Eesti Ühingu Toimetised: STLIEÜ IV aastakonverents; 14-15.juuni 2002; Palmse mõis. 49.
1.1.
2001
Uuskula, A.; Plank, T.; Lassus, A.; Bingham, JS. (2001). Sexually transmitted infections in Estonia - syndromic management of urethritis in a European country? International Journal of STD & Aids, 12 (8), 493−498.
1.1.
2001
Wilson, TE.; Uuskula, A.; Feldman, J.; Holman, S.; Dehovitz, J. (2001). A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia. Sexually Transmitted Diseases, 28 (11), 624−629.
3.3.
2001
Napritson, K.; Raudsepp, H.; Uusküla, A.; Kukk, T.; Kangur, A.; Karelson, M.; Lehtmets, A.; Rajangu, H.; Silm, H. (2001). Akne ravijuhend. Lege Artis (24−26).. Tallinn: Lege Artis.
1.3.
2000
Uusküla, A.; Silm, H. (2000). Genitaalsed mükoplasmainfektsioonid. Eesti Arst, 5, 282−286.
6.6.
1999
Põder, A.; Uusküla, A.; Vendirevskih, G.; Silm, H.; Raukas, E.; Brilene, T. (1999). Meeste uretriidi ja naiste endotservitsiidi/kolpiidi etioloogiline struktuur Eestis. Eesti Naistearstide Seltsi Teataja, 9, 36−41.
1.1.
1997
Uuskula, A.; Silm, H.; Vessin, T. (1997). Sexually transmitted diseases in Estonia: Past and present. International Journal of STD & Aids, 8 (7), 446−450.
10.01.2020
Detailne otsing
  • Leitud 33 kirjet
ProgrammLiikNumberNimiProjekti algusProjekti lõppVastutav täitjaAsutusFinantseerijapoolne rahastamine
MUUSARTH12115T (3.2.1001.11-0020)Bridging the gap in knowledge and practice of prevention and care for HIV in Estonia24.10.201131.08.2015Anneli UuskülaTartu Ülikool514 964,50 EUR
MUUMARTH07245Capacity building for disease surveillance and health monitoring in Estonia.01.12.200730.04.2011Anneli UuskülaTartu Ülikool769 311,99 EUR
MUUMARTH04069Collaborative response to Tackle HIV Epidemic in Baltics: International and Multidisciplinary Workshop to Prioritize Areas and Methods of Research / HIV nakkus ja sellega seostuvad probleemid Balti riikides - teadusuuringute ja ennetustegevuse priori01.07.200431.12.2004Anneli UuskülaTartu Ülikool13 003,08 EUR
MUUMMVPT15062Combined prevention to reduce initation into injecting drug use30.09.201531.01.2020Anneli UuskülaTartu Ülikool, Arstiteaduskond, Tervishoiu instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut789 094,53 EUR
MUUMARTH15062Combined prevention to reduce initation into injecting drug use01.03.201531.01.2016Anneli UuskülaTartu Ülikool, Arstiteaduskond, Tervishoiu instituut; Tartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut138 000,00 EUR
MUUMARTH06177Development of an Intervention/Prevention to Block Transmission from Injection Drug Users to Their Sex Partners, Culturally Appropriate for Ethnic and Non-Ethnic Estonians in Estonia.07.08.200606.01.2008Anneli UuskülaTartu Ülikool46 037,93 EUR
SFSF0182648s04Eesti elanike tervise seisundit mõjutavad tegurid: mõõtmismetoodika ja sekkumiste tulemuslikkus.01.01.200431.12.2008Anneli UuskülaTartu Ülikool, Arstiteaduskond302 800,62 EUR
MUULP2EC14127Eesti meeste hoiakute ja käitumise uuring: tervis, haridus, tööhõive, ränne ja pereloome15.08.201412.01.2015Kerly EspenbergTartu Ülikool; Tartu Ülikool, Tartu Ülikooli Euroopa Kolledž, Rakendusuuringute keskus Socialia39 993,75 EUR
EMPEMP416Emakakaelavähi likvideerimisele suunatud nutikad ja personaalsed lahendused sõeluuringuks01.10.201930.09.2023Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut907 847,00 EUR
ETFETF7416Enneaegne suremus ja alkoholi tarvitamine: Eesti andmebaaside ja terviseuuringute süvaanalüüs tõendupõhise teabe saamiseks01.01.200831.12.2010Kersti PärnaTartu Ülikool, Arstiteaduskond34 759,25 EUR
IUTIUT34-17Epidemioloogilised ja rahvatervise uuringud tõenduspõhiseks otsustamiseks ja siirdemeditsiini toetamiseks01.01.201531.12.2020Anneli UuskülaTartu Ülikool, Meditsiiniteaduste valdkond, peremeditsiini ja rahvatervishoiu instituut399 600,00 EUR
MUUMARTH08018European network for promoting health of residents in psychiatric and social care institutions (Psühhiaatriliste raviasutuste ja hooldekodude teenuste kasutajate füüsilise tervise edendamise Euroopa võrgustik)01.01.200831.12.2010Anneli UuskülaTartu Ülikool22 934,95 EUR
MUUMARTH10189Genitaaltüügaste levimus: uuring kolmes Balti riigis01.12.201030.11.2012Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut86 500,01 EUR
MUUMARTH08228HIV ülekanne narkootikumide kasutajate hulgas Tallinnas, Eestis01.01.200930.07.2010Anneli UuskülaTartu Ülikool35 727,89 EUR
MUUMARTH07237HIV-nakkuse kandjate HAART ravisoostumus ja seda mõjutavad tegurid01.01.200730.09.2011Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut68 555,79 EUR
MUUMARTH10174HIVi levikut mõjutavad tegurid ja teenuste kättesaadavus venemaal ja Eestis elavate süstivate narkomaanide seas01.09.201031.08.2015Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond, Tervishoiu instituut398 639,07 EUR
MUUSP1GV12134T (3.2.1001.11.0033)Implementation of Individualized Medicine: Education, Prediction and Treatment” (IndiMed)01.01.201231.08.2012Krista FischerTartu Ülikool558 605,14 EUR
MUULARTH08107Inimese papilloomiviiruse (HPV) levimuse hindamine.01.06.200830.09.2008Anneli UuskülaTartu Ülikool6 454,76 EUR
MUUVARTH12013Klamüdioosi kontroll Euroopas02.02.201231.12.2014Anneli UuskülaTartu Ülikool5 400,00 EUR
MUUMARTH09110Multiple Prevention Packages for IDUs in Estonia08.06.200931.05.2013Anneli UuskülaTartu Ülikool; Tartu Ülikool, Arstiteaduskond283 100,80 EUR
SFSF0182128s02Naha- ja suguhaiguste patogeneesi molekulaarsed mehhanismid ja epidemioloogilised aspektid Eestis01.01.200231.12.2006Helgi SilmTartu Ülikool, Arstiteaduskond133 894,91 EUR
MUUMARTH04048Narkomaanide poolt kasutatud süstalde uuring: B-hepatiidi, C-hepatiidi ja inimese immuunpuudulikkuse viiruse markerite määramine01.05.200431.12.2005Anneli UuskülaTartu Ülikool16 361,38 EUR
MUULARTH08024Osteoporoosi ennetamise projekti laiendamise analüüs.13.02.200831.10.2008Anneli UuskülaTartu Ülikool6 885,78 EUR
ETFETF9368Osteoporootilise luumurruga seostud kulude ja elukvaliteedi uuring01.01.201231.12.2015Anneli UuskülaTartu Ülikool, Arstiteaduskond60 000,00 EUR
ETFETF5792Patsiendi omaosaluse mõju tervishoiuteenuste kättesaadavusele01.01.200431.12.2007Anneli UuskülaTartu Ülikool, Arstiteaduskond23 772,44 EUR